Laquinimod · The pivotal CONCERTO clinical study is continuing according to plan and results are expected in 2016. · In May 2014, EMA's Committee for Medicinal Products for Human Use (CHMP) announced that the risks observed in animal studies did not prevent registration for treatment in humans. CHMP confirmed its January 2014 risk-benefit opinion, that is, to at this stage recommend against approval of laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS) in the European Union (EU). · In September 2014, new follow-up data was presented from the extension studies following ALLEGRO and BRAVO. No new risks were identified and the rates of adverse events (AEs) were lower in the open-label extensions than in the core studies. Less than 3 percent of patients discontinued treatment due to AEs during these extensions. The safety profile of laquinimod when used in a longer- term setting was hence confirmed. · In November 2014, it was announced that Teva will initiate a Phase II trial with laquinimod for the treatment of primary progressive multiple sclerosis (PPMS). The first patient had been screened in a Phase II trial in Huntington's disease. Tasquinimod · The Phase III study 10TASQ10 is proceeding as planned; the final analysis of progression-free survival (PFS) and overall survival (OS) is expected during the first half of 2015. · In February 2014, Ipsen launched a randomized, double-blind, placebo- controlled Phase III study of tasquinimod in chemo-naive castrate-resistant prostate cancer (CRPC) patients in Asia. · In September 2014, Ipsen announced the preliminary results of the clinical Phase II proof-of-concept study in four cancer indications. The study for the treatment of hepatocellular carcinoma is continuing with results expected in 2015. The results do not support the further development of tasquinimod for the treatment of patients with advanced ovarian, renal cell or gastric carcinomas. The primary endpoint of the study was progression-free survival (PFS) at a predefined time for each cohort. ANYARA · During the year, it was decided to only conduct commercial activities in relation to the project. Out-licensing activities are ongoing. Paquinimod (57-57) · During the year, it was decided to only conduct commercial activities in relation to the project. Out-licensing activities are ongoing. ISI · The project is proceeding according to plan. The selection of the first candidate drug is planned to take place during 2015. Financial information · A rights issue totaling approximately SEK 225 M was completed in December 2014 and was oversubscribed by 24 percent. Financial summary MSEK Oct. - Dec. Jan. - Dec. 2014 2013 2014 2013 --------------------------------------------------------------- Net sales 2.9 4.0 10.4 116.0 Operating loss -55.6 -80.4 -228.5 -209.0 Loss for the period -57.0 -82.1 -231.5 -212.1 Loss per share (SEK) -0.73 -1.07 -3.02 -2.81 Cash and cash equivalents (Dec 31) 328.5 376.2 For further information, please contact: Tomas Leanderson, President and CEO Active Biotech AB Tel: +46 (0)46 19 20 95 (Corp. Reg. No. 556223-9227) Box 724, SE-220 07 Lund, Sweden Hans Kolam, CFO Tel: +46 (0)46 19 20 00 Tel: +46 (0)46 19 20 44 Fax: +46 (0)46 19 11 00 The report is also available at www.activebiotech.com [HUG#1893344]
Active Biotech AB Year-end report January - December 2014
Top 10 Most Recent News Articles
Nailah Thorbourne's Vlair Shapewear: Fashion Freedom
Fashion with a Punch: Nailah Thorbourne's New Venture You'd think from the way the fashion industry's been humming along that someone would've cracked the code on shapewear a long time ago, right? But alas, it takes Nailah Thorbourne to step out of Brick & Lace's spotlight and into this shapely market with Vlair Shapewear. Apparently, what most overlooked in comfort, she...
Continue Reading
SOA Elects New Leaders for 2026: A Look Ahead
A New Lineup for SOA's Board in 2026 On the financial frontlines, few organizations hold the clout that the Society of Actuaries (SOA) wields. With their latest round of elections completed, they've named five fresh Board members along with both a new President Elect and Vice Chair for the upcoming 2026-2027 term. These folks are gearing up to take the stage right after...
Continue Reading
Beasley and Vegas Golden Knights Partner for Broadcast
Strategic Moves on the Airwaves The Vegas Golden Knights are skating into a new era of broadcasting. Teaming up with Beasley Media Group, they've inked a multiyear deal that makes the media outfit their official audio partner. Dropping the puck on this relationship means folks in Southern Nevada can catch the action on Beasley's English and Spanish stations. It's a hefty...
Continue Reading
Books-A-Million's Impactful 2026 Coffee for Troops Campaign
A Modest Cup, A Massive Impact Ever wonder how something as simple as a bag of coffee could bridge the gap between a service member far from home and their loved ones? Well, Books-A-Million has got that figured out, and they're taking it to another level with their 2026 Coffee for the Troops campaign. This isn't just about a hot brew; it's about stirring up a storm of...
Continue Reading
LifeLabs' AI Program: A Manager's New Toolbox
Management In the Age of AI: New Frontiers Gone are the days when a simple software update meant staying competitive. We're in a new era, folks—one where AI isn't just a handy tool—it's reshaping entire industries. But here's the kicker: all the fancy tech in the world won't do squat without savvy managers who know how to drive adoption. Yup, that's the naked truth,...
Continue Reading
Multiply's AI Agent Tackles $126K Google Ads Waste
AI Steps In Where Marketers Hit a Wall Picture this: marketers drowning in search terms flying at them faster than they can blink. Multiply's new AI-powered Ad Spend Recovery Agent steps in, claiming to save an eye-watering $126,000 per year by cutting Google Ads waste. Talk about having a hawk-eyed auditor sifting through your accounts. Shaking Up Traditional Automation...
Continue Reading
AHN Healthcare@Home Celebrates Fourth Top Workplace Win
Four-Time Top Workplace Champ You want to talk consistency? Let's talk about AHN Healthcare@Home pulling in that Pittsburgh Top Workplace award four years running. It's no small feat, especially in the healthcare sector where employee burnout isn't just a buzzword—it's a daily challenge. How did a home health and hospice outfit like AHN land this honor? Well, it's all...
Continue Reading
Alito's Recusal: Supreme Court Climate Case Shaker
Justice Alito Bows Out from A High-Stakes Climate Battle September 28, 2026, marked a notable turn in the legal landscape. Supreme Court Justice Samuel Alito chose to step away from a case that's got every investor, lawyer, and policy wonk on the edge of their seats—Suncor v. Boulder. This isn't about just any old courtroom squabble; it's a landmark climate case poised...
Continue Reading
Claigan Webinar Tackles Prop 65 Warnings for 2028
Buckle up, folks. Here comes a wake-up call for businesses playing loose with their compliance homework on California's Prop 65, thanks to Claigan's latest announcement. They're hosting a webinar on October 7, 2026, gearing up everyone who'll listen for the changes hitting the books in 2028. We’re zooming past the days of generic warnings; pretty soon, it'll be all...
Continue Reading
Janitorial Wages Soar 26.7% Amid High Annual Openings
Janitorial Sector Faces Wage Surge and Employment Shifts Look, if you thought the world of janitorial work was all brooms and mops without a paycheck edge, think again. From 2020 to 2025, wages for janitors and building cleaners didn't just tip-toe up the ladder—they practically sprinted, climbing 26.7%. BLS data laid this one out, with hourly pay shooting from $13.98...
Continue ReadingTop 5 Most Recently Viewed Articles
Projected Growth of the Power Transformer Market by 2032
Overview of the Global Power Transformer Market The global power transformer market reflects an evolution driven by the increasing demands for reliable electricity delivery and advancements in technology. As we delve deeper into this sector, it's evident that the market is on an upward trajectory, projected to achieve a valuation of USD 57.37 billion by the end of the...
Continue Reading
Nyxoah Expands Operations for Obstructive Sleep Apnea Patients
Nyxoah's Growing Influence in the Middle East Region Nyxoah, a pioneer in medical technology, is amplifying its footprint in the Middle East, signifying their commitment to advancing treatments for Obstructive Sleep Apnea (OSA). With the introduction of new centers across major cities like Dubai, Kuwait, and Abu Dhabi, the company is enhancing patient accessibility to...
Continue Reading
Newegg and PayPal Revolutionize Shopping with AI Integration
Newegg and PayPal Join Forces for Enhanced Shopping Newegg Commerce, Inc. (NASDAQ: NEGG), a prominent player in the technology and computer product sphere, has recently taken a significant leap by integrating PayPal's cutting-edge services tailored for AI-driven shopping experiences. This collaboration aims to transform how customers discover and purchase products in...
Continue Reading
Dynamic Funds Unveils New Cash Distribution Details for ETFs
Dynamic Funds Cash Distributions Announcement Dynamic Funds has made an important announcement regarding the cash distributions for September 2025, specifically for its Dynamic Active ETFs and ETF Series. These funds, which are prominently listed on the TSX, will disburse cash distributions either on a monthly or quarterly basis. Unitholders who are on record as of...
Continue Reading
Tesla Encourages Buyers to Secure EV Purchases Before Credit Cut
Tesla's Urgent Call to Action for EV Buyers Tesla Inc. (NASDAQ: TSLA) is actively encouraging its customers to finalize their vehicle purchases to take advantage of the Federal Electric Vehicle (EV) credit. They issued this reminder ahead of the approaching deadline on September 30, as the company anticipates an increase in third-quarter deliveries, which are projected to...
Continue Reading